The second-line endocrine therapy landscape in hormone receptor (HR)-positive, HER2-negative advanced breast cancer is ...

The Post Surgery Everyday Bra, manufactured for brands by MAS Femography, combines medical insight and apparel innovation, ...

By embedding standardized questionnaires and algorithms into routine visits, providers can evaluate risk factors such as age, ...

The drugmaker said the results for giredestrant open the door to adding a treatment option at an early stage of the cancer, ...

Roche's experimental oral drug giredestrant has been shown to cut the risk of recurrence of a common form of breast cancer ...

The rationale is really strong since we're often making decisions for our patients based on single features or ...

A real-world analysis of more than 60,000 patients in the US finds median survival increased by almost 7 months from 2011 to ...

The study sought to answer questions about how breast cancer risk differs by type of hormonal contraceptive. Doctors say the ...

During a routine mammogram, doctors found something unusual in Patty Schone’s left breast. But the real danger was actually ...

Roche claimed the results make its drug giredestrant the first of its kind, a so-called oral SERD, to show a benefit in the ...

Topline data were announced from a phase 3 trial evaluating giredestrant for the adjuvant treatment of estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative, ...

Riko's Pizza ("Riko's" or the "Company"), a fast-growing pizza restaurant and bar franchise known for its thin-crust, ...